Data / Drug companies / Farmacias De Similares TX LLC
Farmacias De Similares TX LLC: 27 products in the FDA NDC directory, labeler code 85786
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Farmacias De Similares TX LLC (labeler code 85786) lists 27 products in the FDA National Drug Code Directory, covering 23 finished drugs by generic name. By type: 27 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on September 1, 2026.
The request: Watch Farmacias De Similares TX LLC (FDA labeler code 85786): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 85786
- Products in commercial distribution
- 27
- Packages
- 27
- Finished drugs by generic name
- 23
- Prescription products
- 0
- Over the counter products
- 27
- Flagged as original packager
- 26 of 26 products that carry the flag
- Started marketing in the last 12 months
- 21
- Earliest marketing start
- August 11, 2025
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 20 | 74.1% |
| Generic drugs (ANDA) | 7 | 25.9% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 27 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Acetaminophen | 2 | 214 |
| Guaifenesin | 2 | 123 |
| Diphenhydramine hcl | 1 | 99 |
| Calamine 8%, zinc oxide 8% | 1 | 1 |
| Bismuth subsalicylate 525 mg | 1 | 6 |
| Fexofenadine hcl | 1 | 39 |
| Acetaminophen, diphenhydramine hcl | 1 | 42 |
| Docusate sodium 100mg | 1 | 3 |
| Acetaminophen, diphenhydramine hydrochloride | 1 | 14 |
| Oxymetazoline hcl | 1 | 15 |
| Povidone iodine | 1 | 14 |
| Acetaminophen 250 mg, aspirin 250 mg, and caffeine 65 mg | 1 | 1 |
| Aspirin delayed release 81mg | 1 | 1 |
| Aspirin | 1 | 134 |
| Dextromethorphan hbr, guaifenesin | 1 | 67 |
| Naproxen sodium | 1 | 100 |
| Ibuprofen 200 mg | 1 | 2 |
| Cetirizine hydrochloride 10 mg | 1 | 2 |
| Levocetirizine dihydrochloride | 1 | 52 |
| Sennosides 8.6mg | 1 | 3 |
| Loratadine | 1 | 125 |
| Simethicone 180 mg | 1 | 3 |
| Magnesium citrate | 1 | 29 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, coated | 7 | 25.9% |
| Capsule, liquid filled | 4 | 14.8% |
| Tablet, film coated | 4 | 14.8% |
| Tablet | 3 | 11.1% |
| Tablet, extended release | 2 | 7.4% |
| Lotion | 1 | 3.7% |
| Suspension | 1 | 3.7% |
| Spray | 1 | 3.7% |
| Liquid | 1 | 3.7% |
| Tablet, chewable | 1 | 3.7% |
| Syrup | 1 | 3.7% |
| Solution | 1 | 3.7% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Adult Low Dose Chewable Aspirin | 85786-110 | Tablet, chewable | Over the counter monograph drugs | September 1, 2026 |
| Dr. Simi Children s Cough | 85786-604 | Syrup | Over the counter monograph drugs | May 8, 2026 |
| Dr. Simi Allergy Relief | 85786-202 | Tablet | Over the counter monograph drugs | April 20, 2026 |
| Dr. Simi Pain Reliever PM | 85786-108 | Tablet | Over the counter monograph drugs | April 10, 2026 |
| Dr. Simi Mucus Relief | 85786-302 | Tablet, extended release | Generic drugs (ANDA) | April 8, 2026 |
| Oxymetazoline HCl 0.05% | 85786-205 | Spray | Over the counter monograph drugs | April 8, 2026 |
| Fexofenadine HCl 180 mg | 85786-204 | Tablet | Generic drugs (ANDA) | April 8, 2026 |
| Calamine | 85786-703 | Lotion | Over the counter monograph drugs | April 6, 2026 |
| Levocetirizine Dihydrochloride | 85786-206 | Tablet, film coated | Generic drugs (ANDA) | April 6, 2026 |
| Povidone Iodine 10% | 85786-702 | Liquid | Over the counter monograph drugs | April 1, 2026 |
| Magnesium Citrate | 85786-503 | Solution | Over the counter monograph drugs | April 1, 2026 |
| Dr. Simi Nighttime Cold and Flu | 85786-602 | Capsule, liquid filled | Over the counter monograph drugs | March 30, 2026 |
| Dr. Simi Daytime Cold and Flu | 85786-601 | Capsule, liquid filled | Over the counter monograph drugs | March 30, 2026 |
| Dr. Simi Stomach Relief | 85786-802 | Suspension | Over the counter monograph drugs | March 24, 2026 |
| Docusate sodium 100mg | 85786-502 | Capsule, liquid filled | Over the counter monograph drugs | January 1, 2026 |
| Dr Simi Regular Strength Sennosides 8.6mg | 85786-501 | Tablet, coated | Over the counter monograph drugs | January 1, 2026 |
| Simethicone 180 MG | 85786-401 | Capsule, liquid filled | Over the counter monograph drugs | January 1, 2026 |
| Dr Simi Cetirizine Hydrochloride 10 mg | 85786-203 | Tablet, film coated | Generic drugs (ANDA) | January 1, 2026 |
| Ibuprofen 200 mg | 85786-107 | Tablet, coated | Generic drugs (ANDA) | January 1, 2026 |
| Aspirin delayed release 81mg | 85786-106 | Tablet, coated | Over the counter monograph drugs | January 1, 2026 |
| Dr Simi Extra Strength Acetaminophen 250 mg, Aspirin 250 mg, and Caffeine 65 mg | 85786-105 | Tablet, coated | Over the counter monograph drugs | January 1, 2026 |
| Dr Simi All Day Pain Relief | 85786-104 | Tablet, film coated | Generic drugs (ANDA) | August 17, 2025 |
| Dr Simi Mucus Relief Expectorant | 85786-301 | Tablet, extended release | Over the counter monograph drugs | August 15, 2025 |
| Dr Simi All Day Allergy Relief | 85786-201 | Tablet, film coated | Generic drugs (ANDA) | August 14, 2025 |
| Dr Simi Pain Relief | 85786-103 | Tablet, coated | Over the counter monograph drugs | August 13, 2025 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.